Menu INSIDE SERES Seres is defined by its extraordinary people, and their passion is what drives us on our mission to help patients. VIEW ALL OPEN POSITIONS Make your mark on the medical breakthroughs of tomorrow At Seres, we’re leading the microbiome revolution — and our most revolutionary asset is our team. We’re courageous and deeply collaborative, and above all we’re passionate about the commitment we’ve made to blaze a new trail for the benefit of patients. We are proud of our achievements thus far — including moving multiple novel therapeutics to the clinic for patients — achievements made possible by our amazing teams across the company. Just as combinations of bacteria perform challenging biological tasks together, integration of our diverse expertise and insights is allowing us to drive the microbiome revolution and change the face of medicine for patients in need. Join the revolution. Explore our open jobs below. GET TO KNOW US OPEN POSITIONS Meet our team One of the most exciting projects I’ve been involved in is putting together our state-of-the-art gnotobiotic program. This technology is really unique to Seres, and I was very proud to have been part of it. Outside of work I enjoy travel, riding motorcycles, and I am an avid bar trivia connoisseur. Keith H. MANAGER, IN VIVO PHARMACOLOGY MEET OUR TEAM OPEN POSITIONS Get to know us There’s so much more of Seres to discover. Find our team on LinkedIn and connect with us to start a conversation. SEE WHO YOU KNOW AT SERES © 2021 Seres Therapeutics Privacy Policy Terms of use Follow us on Linkedin Follow us on Twitter Follow us on Facebook

Menu OPEN POSITIONS Clinical Development CMC G&A Quality Systems R&D GENERAL INTEREST © 2021 Seres Therapeutics Privacy Policy Terms of use Follow us on Linkedin Follow us on Twitter Follow us on Facebook

Menu OUR PROGRAMS Seres’ microbiome therapeutics represent an entirely new class of medicines with promise across a wide range of diseases. PRE-CLINICAL PHASE 1 PHASE 2 PHASE 3 COLLABORATORS SER-109 C. difficile SER-287 Ulcerative Colitis SER-301 Ulcerative Colitis SER-155 Infection & GvHD Oncology Scientific literature C. diff & infectious disease Inflammatory bowel disease & ulcerative colitis Immuno-oncology Infection & GvHD © 2021 Seres Therapeutics Privacy Policy Terms of use Follow us on Linkedin Follow us on Twitter Follow us on Facebook